Regulation of costimulatory signal in maternal-fetal immune tolerance

American Journal of Reproductive Immunology

Volumn 66, Issue 2, 2011, Pages 76-83

  Jin, Li Ping ^a   Fan, Deng Xuan ^a   Li, Da Jin ^a,b  

^a FUDAN UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Costimulatory signal; Maternal fetal immunotolerance; Pregnancy wastage

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7; UNCLASSIFIED DRUG;

DECIDUA; FETUS WASTAGE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; T LYMPHOCYTE;

ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CTLA-4 ANTIGEN; FEMALE; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 79960178581     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00982.x     Document Type: Review

References (57)

1. Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Soc Exp Biol 1953; 7:320-338.
2. Sacks G, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today 1999; 20:114-118.
3. de Groot CJ, O'Brien TJ, Taylor RN: Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol 1996; 175:24-29.
4. + T cells in the decidua of normal and abnormal early pregnancies. Hum Immunol 1999; 60:791-797.
5. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC: A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9:163-174.
6. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S: Immunology of preeclampsia. Chem Immunol Allergy 2005; 89:49-61.
7. Bretscher P: The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992; 13:74-76.
8. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 1990; 248:1349-1355.
9. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165:302-319.
10. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994; 15:321-331.
11. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-258.
12. Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA: CD-28 co-stimulation promotes the production of Th2 cytokines. J Immunol 1997; 158:658-665.
13. Chambers CA, Allison JP: Costimulatory regulation of T cell function. Curr Opin Cell Biol 1999; 11:203-210.
14. Liu Y: Is CTLA-4 a negative regulator for T-cell activation? Immunol Today 1997; 18:569-572.
15. Chambers CA: The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001; 22:217-221.
16. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH: CTLA-4 and T cell activation. Curr Opin Immunol 1999; 11:294-300.
17. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM: The role of B7-1/B7-2: CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 1996; 153:5-26.
18. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchat JF, Ellis J, Bonnefoy JY: CD86 (B7-2) on human B cells. J Biol Chem 1997; 272:15613-15619.
19. Natarajan K, Sahoo NC, Rao KVS: Signal thresholds and modular synergy during expression of costimulatory molecules in B lymphocytes. J Immunol 2001; 167:114-122.
20. Croft M, Joseph SB, Miner KT: Partial activation of naïve CD4 T cells and toerance induction in response to peptide presented by resting B cells. J Immunol 1997; 159:3257-3265.
21. + T cells. J Exp Med 1998; 188:1977-1983.
22. Lenschow DJ, Zeng Y, Hathcock KS, Zuckerman LA, Freeman G, Thistlethwaite R, Gray GS, Hodes RJ, Bluestone JA: Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60:1171-1178.
23. Kano M, Bashuda H, Yagita H, Okumura K, Morishita Y: A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice. Transplantation 1998; 65:837-843.
24. Kagaya F, Hori J, Kamiya K, Kaji Y, Oshika T, Amano S, Yamagami S, Tsuru T, Tanaka S, Matsuda H, Yagita H, Okumura K: Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86. Exp Eye Res 2002; 74:131-139.
25. Lombardi V, Singh AK, Akbari O: The Role of Costimulatory Molecules in Allergic Disease and Asthma. Int Arch Allergy Immunol 2010; 151:179-189.
26. Olivares EG, Montes MJ, Oliver C, Galindo JA, Ruiz C: Cultured human decidual stromal cells express B7-1 (CD80) and B7-2 (CD86) and stimulate allogeneic T cells. Biol Reprod 1997; 57:609-615.
27. Lutz M, Schuler G: Immature, semi-immature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-449.
28. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
29. Morelli AE, Thomson AW: Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196:125-146.
30. Laskarin G, Kämmerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM: Antigen-Presenting Cells and Materno-Fetal Tolerance: An Emerging Role for Dendritic Cells. Am J Reprod Immunol 2007; 58:255-267.
31. + dendritic cells. Am J Pathol 2000; 157:159-169.
32. Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, Miyawaki T, Saito S: Predominance of Th2-promoting dendritic cells in early human pregnancy deciduas. J Leukoc Biol 2003; 74:514-522.
33. Bachy V, Williams DJ, Ibrahim MA: Altered dendritic cell function in normal pregnancy. J Reprod Immunol 2008; 78:11-21.
34. Blois S, Tometten M, Kandil J, Hagen E, Klapp BF, Margni RA, Arck PC: Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J Immunol 2005; 174:1820-1829.
35. Askelund K, Liddell HS, Zanderigo AM, Fernando NS, Khong TY, Stone PR, Chamley LW: CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta 2004; 25:140-145.
36. Blois SM, Kammerer U, Alba Soto C, Tometten MC, Shaikly V, Barrientos G, Jurd R, Rukavina D, Thomson AW, Klapp BF, Ferna'ndez N, Arck PC: Dendritic cells: key to fetal tolerance? Biol Reprod 2007; 77:590-598.
37. + regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages a preliminary report. Am J Reprod Immunol 2009; 61:136-146.
38. Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS: B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003; 68:1496-1504.
39. Petroff MG, Kharatyan E, Torry DS, Holets L: The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta. Am J Pathol 2005; 167:465-473.
40. Repnik U, Tilburgs T, Roelen DL, van der Mast BJ, Kanhai HH, Scherjon S, Claas FH: Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry. Placenta 2008; 29:405-412.
41. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O: Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 2003; 131:498-505.
42. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10:347-353.
43. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH, Scherjon SA: Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27(Suppl A):S47-S53.
44. Nagamatsu T, Schust DJ: The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod Sci 2010; 17:209-218.
45. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001; 2:64-68.
46. Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S: IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005; 11:865-870.
47. Rüter J, Hoffmann T, Heiser U, Demuth HU, Arck PC, Klapp BF, Hildebrandt M: The expression of T-cell surface antigens CTLA-4, CD26, and CD28 is modulated by inhibition of dipeptidylpeptidase IV (DPP IV, CD26) activity in murine stress-induced abortions. Cell Immunol 2002; 220:150-156.
48. Wang X, Ma Z, Hong Y, Lu P, Lin Q: Expression of CD28 and cytotoxic T lymphocyte antigen 4 at the maternal-fetal interface in women with unexplained pregnancy loss. Int J Gynaecol Obstet 2006; 93:123-129.
49. Jin LP, Chen QY, Zhang T, Guo PF, Li DJ: The CD4+ CD25bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol 2009; 133:402-410.
50. Zhou WH, Dong L, Du MR, Zhu XY, Li DJ: Cyclosporin A improves murine pregnancy outcome in abortion-prone matings: involvement of CD80/86 and CD28/CTLA-4. Reproduction 2008; 135:385-395.
51. Jin LP, Zhou YH, Wang MY, Zhu XY, Li DJ: Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection of the allogeneic fetus in abortion-prone matings, J. Reprod Immunol 2005; 65:133-146.
52. Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, Huang X, Garcia B, White D, Dutartre P, Jevnikar AM, Zhong R: Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance. J Immunol 2003; 170:1304-1312.
53. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle RJ, Coyle A, Mellor AL, Khoury SJ, Sayegh MH: A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005; 202:231-237.
54. Nishihara M, Gotoh M, Ohzato H, ohta Y, Lou Z, Dono K, Umeshita K, Sakon M, Monten M, Yagita H, Okumura K, Miyasaka M: Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts. Transplantation 1997; 64:965-970.
55. Luo ZJ, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M: Anergic T cells generated in vitro suppress rejection response to islet allografts. Transplantation 2000; 69:2144-2148.
56. Jin LP, Li DJ, Zhang JP, Wang MY, Zhu XY, Zhu Y, Meng Y, Yuan MM: Adoptive transfer of paternal antigen-hyporesponsive T cells induces maternal tolerance to the allogeneic fetus in abortion-prone matings. J Immunol 2004; 173:3612-3619.
57. Jin LP, Zhou Y-H, Zhu XY, Wang MY, Li DJ: Adoptive transfer of paternal antigen-hyporesponsive T cells facilitates a Th2 bias in peripheral lymphocytes and at materno-fetal interface in murine abortion-prone matings. Am J Reprod Immunol 2006; 56:258-266.